Short amplicon reverse transcription-polymerase chain reaction detects aberrant splicing in genes with low expression in blood missed by ribonucleic acid sequencing analysis for clinical diagnosis.

Authors:
Wai HA; Constable M; Drewes C; Davies IC; Svobodova E and 10 more

Journal:
Hum Mutat

Publication Year: 2022

DOI:
10.1002/humu.24378

PMCID:
PMC9325405

PMID:
35476365

Journal Information

Full Title: Hum Mutat

Abbreviation: Hum Mutat

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability statement variants of uncertain significance information were submitted to the clinvar database ( https://www ncbi nlm nih gov/clinvar/ ) with accession numbers from scv002106369 to scv002106379. distribution of sequencing quality error rate distribution a/t/g/c distribution the composition of raw data and data quality summary were mentioned in the supplementary data (data s1 )."

Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST The authors declare no conflicts of interest."

Evidence found in paper:

"This study was supported by the National Institute for Health Research (RP‐2016‐07‐011 research professorship awarded to Diana Baralle). The authors would like to thank all the patients recruited for this study and the CRN Musketeers' Memorandum. The authors acknowledge the IRIDIS 4 High Capacity Performance Computer and the supporting team at the University of Southampton. They would also like to thank the technical teams of Duthie and IDS buildings, University of Southampton, for their support in day‐to‐day lab work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025